Purpose: To determine and compare the interobserver variability of three clinically frequently used radiotracers targeting the prostate specific membrane antigen (PSMA), namely 18F-DCFPyL, 18F-PSMA-1007 and 68Ga-PSMA-11, in primary prostate cancer (PCa) staging. Methods: Patients with newly diagnosed PCa in whom a PSMA-PET/CT was performed for primary staging purposes, were retrospectively included. All PSMA-PET/CT images were centrally overread within a high-volume PCa center and original reports (from referring hospitals) were compared to overread reports (from the overreading hospital). To assess the interobserver variability a Cohen’s kappa analysis was used. To study possible differences in interobserver variability between the three used PSMA-radiotracers, multivariate logistic regression analyses were used. Results: In total, 584 patients with newly diagnosed PCa were included in the analysis. 18F-DCFPyL, 18F-PSMA-1007 and 68Ga-PSMA-11 were undertaken in 205/584 (35.1%), 168/584 (28.8%) and 211/584 (36.1%) patients, respectively. The overall agreement (Cohen’s kappa analysis) for locoregional lymph-node metastases, distant lymph-node metastases, bone metastases and visceral metastases was 0.86, 0.86, 0.80 and 0.46, respectively. 18F-PSMA-1007 showed a significantly higher interobserver variability regarding bone metastases, compared to 18F-DCFPyL and 68Ga-PSMA-11 (P = 0.001 and P = 0.03, respectively). Additionally, 18F-PSMA-1007 showed a significantly higher interobserver variability regarding overall agreement and locoregional lymph-node metastases, compared to 18F-DCFPyL (p<0.001 and P = 0.01, respectively). Conclusion: The interobserver variability differs among the three clinically frequently used PSMA-radiotracers (18F-DCFPyL, 18F-PSMA-1007 and 68Ga-PSMA-11) in patients with newly diagnosed PCa. The agreement in bone metastases is significantly worse for 18F-PSMA-1007, mainly due to non-specific tracer uptake in osseous structures. Based on our findings, PSMA-PET/CT scans undertaken with 18F-PSMA-1007 in primary staging should be interpreted carefully and training in interpreting this specific PSMA-radiotracer is strongly advised.